Article
Emerging views of statin pleiotropy and cholesterol lowering
3 Feb 2021
Abstract excerpt
Over the past four decades, no class of drugs has had more impact on cardiovascular health than the 3-hydroxy-methylglutaryl coenzyme A reductase inhibitors or statins. Developed as potent lipid-lowering agents, statins were later shown to reduce morbidity and mortality of patients who are at risk for cardiovascular disease. However, retrospective analyses of some of these clinical trials have uncovered some...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
